local_hospital

Katholisches Klinikum Bochum gGmbH

Address
lock Available on a paid plan

Diseases [C] - Pathological Conditions, Signs and Symptoms [C23]

The Center for Sexual Health and Medicine focuses on chronic pain conditions, studying diseases such as diabetic polyneuropathy, peripheral neuropathy after trauma or surgery, central neuropathy, and chronic back pain. The trials aim to evaluate the effectiveness of a new add‑on therapy, AP707, in relieving persistent pain.

  • Chronic Pain due to diabetic polyneuropathy
  • Chronic Pain due to traumatic or post‑operative peripheral Neuropathy
  • Chronic Pain due to central Neuropathy of any Genesis
  • Chronic back pain

At Katholisches Klinikum Bochum gGmbH, investigators are testing AP707 to improve pain management and quality of life for patients with long‑standing neuropathic and musculoskeletal pain.

Site Overview

assignment
7
connected trials
corporate_fare
4
sponsors
science
34
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
7
Total trials linked
Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 2 therapeutic areas and 15 of 34 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
4
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
7
Outperforms 78% of sites
public
Therapeutic diversity
2areas
Outperforms 62% of sites
groups
Sponsor diversity
4sponsors
Outperforms 71% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Katholisches Klinikum Bochum gGmbH

lock Showing 1 of 7 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety Evaluation of Bepirovirsen in HBeAg-Negative Nucleos(t)ide Analogue-Treated Patients with Chronic Hepatitis B: A Phase 3 Randomized StudyGlaxosmithkline Research & Development LimitedPhase IIINot RecruitingJan 2023Mar 2026

IMP list

lock Showing 1 of 34 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Adezunap4Unknown2023-11-022023-11-02

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.